UY33789A - Combinación que comprende un derivado de la familia de las combretastatinas y cetuximab - Google Patents

Combinación que comprende un derivado de la familia de las combretastatinas y cetuximab

Info

Publication number
UY33789A
UY33789A UY0001033789A UY33789A UY33789A UY 33789 A UY33789 A UY 33789A UY 0001033789 A UY0001033789 A UY 0001033789A UY 33789 A UY33789 A UY 33789A UY 33789 A UY33789 A UY 33789A
Authority
UY
Uruguay
Prior art keywords
cetuximab
combination
combretastatinas
family derivative
derivative
Prior art date
Application number
UY0001033789A
Other languages
English (en)
Inventor
Chantal Carrez
Brigitte Demers
Yvette Ruffin
Patricia Vrignaud
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of UY33789A publication Critical patent/UY33789A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/39558—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2863—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators

Abstract

La invención se refiere a una combinación farmacéutica que comprende un derivado de la familia de las combretastatinas, tal como la ombrabulina, que puede estar en forma de base o en forma de una sal farmacéuticamente aceptable, y cetuximab.
UY0001033789A 2010-12-09 2011-12-09 Combinación que comprende un derivado de la familia de las combretastatinas y cetuximab UY33789A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1060293A FR2968557A1 (fr) 2010-12-09 2010-12-09 Combinaison antitumorale comprenant un derive de la famille des combretastatines et le cetuximab

Publications (1)

Publication Number Publication Date
UY33789A true UY33789A (es) 2012-07-31

Family

ID=43837735

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001033789A UY33789A (es) 2010-12-09 2011-12-09 Combinación que comprende un derivado de la familia de las combretastatinas y cetuximab

Country Status (5)

Country Link
AR (1) AR084169A1 (es)
FR (1) FR2968557A1 (es)
TW (1) TW201306833A (es)
UY (1) UY33789A (es)
WO (1) WO2012076688A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2889530A1 (en) * 2012-10-25 2014-05-01 Glaxosmithkline Llc Combination
US20170128592A1 (en) * 2015-10-01 2017-05-11 Indian Institute Of Technology, Bombay Targeted polymeric nano-complexes as drug delivery system
CN112225673B (zh) * 2020-11-13 2022-08-02 义乌市华耀医药科技有限公司 氨基康普立停衍生物及其应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4996237A (en) 1987-01-06 1991-02-26 Arizona Board Of Regents Combretastatin A-4
TW325458B (en) 1993-09-08 1998-01-21 Ajinomoto Kk Stilbene derivatives and pharmaceutical compositions comprising the same for anti-cancer
US5731353A (en) 1993-09-08 1998-03-24 Ajinomoto Co., Inc. Stilbene derivatives and pharmaceutical compositions containing them
TW334418B (en) 1995-03-07 1998-06-21 Ajinomoto Kk Stilbene derivatives and pharmaceutical compositions
CN1140272C (zh) 1998-04-03 2004-03-03 味之素株式会社 抗肿瘤剂
US20020183266A1 (en) 2001-03-15 2002-12-05 Aventis Pharma, S.A. Combination comprising combretastatin and anticancer agents
ATE489080T1 (de) 2001-06-25 2010-12-15 Ajinomoto Kk Antitumorale mittel
FR2838437B1 (fr) 2002-04-11 2004-06-04 Aventis Pharma Sa Procedes de preparation de combretastatines
GB0410817D0 (en) * 2004-05-14 2004-06-16 Angiogene Pharm Ltd Vascular damaging therapy
FR2895258B1 (fr) 2005-12-22 2008-03-21 Aventis Pharma Sa Combinaison comprenant de la combretastatine et des agents anticancereux
RU2010128239A (ru) * 2007-12-13 2012-01-20 Новартис АГ (CH) Комбинации терапевтических средств, предназначенных для лечения рака
US20090209496A1 (en) * 2008-02-15 2009-08-20 David Chaplin Methods and compositions for enhancing the efficacy of rtk inhibitors
FR2945210B1 (fr) * 2009-05-07 2011-07-01 Sanofi Aventis Combinaison antitumorale comprenant l'ave8062 et le sorafenib

Also Published As

Publication number Publication date
AR084169A1 (es) 2013-04-24
TW201306833A (zh) 2013-02-16
WO2012076688A1 (en) 2012-06-14
FR2968557A1 (fr) 2012-06-15

Similar Documents

Publication Publication Date Title
CL2014003136A1 (es) Nuevos diazaespirocicloalcanos y azaespirocicloalcanos; composicion farmaceutica que los contiene y usos.
CL2014002093A1 (es) Compuestos derivados piperidinopirimidinicos; composicion farmaceutica que los comprende; uso en el tratamiento de infecciones viricas.
CO6980625A2 (es) Composiciones que generan perácidos
CR20130406A (es) Composiciones farmacéuticas que comprenden anticuerpos humanos frente a pcsk9
BR112014010290A2 (pt) composição farmacêutica, métodos, composições e usos
BR112014010164A2 (pt) implante de tecido duro
MX2021004211A (es) Composiciones vacuna.
CL2014000447A1 (es) Compuestos derivados de piridina y pirimidina sustituidos, mediadores de quinurenina-3-monooxigenasa; composiciones farmaceuticas que los comprenden; y uso en el tratamiento de una patologia neurodegenerativa, tal como la enfermedad de huntington.
CR20120008A (es) Compuestos y composiciones para el tratamiento de enfermedades parasitarias
ITTO20110641A1 (it) Composizioni farmaceutiche e metodi di trattamento
PE20151435A1 (es) Laquinimod para reducir el dano talamico en la esclerosis multiple
HN2011003403A (es) Sulfonamidas heterociclicas, usos y composiciones farmaceuticas de las mismas
CL2013002905A1 (es) Composición farmacéutica que comprende fimasartan, una sal, solvato o hidrato del mismo y amlodipina, un isómero, sal, solvato o hidrato del mismo; uso en el tratamiento de hipertensión y enfermedades cardiovasculares.
CO6920289A2 (es) Composición farmacéutica oftalmológica tópica que contiene regorafenib.
CO6801754A2 (es) Una composición farmacéutica para tratar una enfermedad en la cavidad oral que comprende rebamipida
CO7010828A2 (es) Preparación farmacéutica que comprende ߖciclodextrina sustituida
IT1397255B1 (it) Struttura di impianto dentale perfezionato.
CO6390102A2 (es) Combinacion anitumoral que comprende ave8062 y sorafenib
MA32461B1 (fr) Dronedarone pour la prevention de cardioversion
SMT201600243B (it) Composizioni farmaceutiche comprendenti anakinra senza citrato
CO6900125A2 (es) Ataud biodegradable
UY33789A (es) Combinación que comprende un derivado de la familia de las combretastatinas y cetuximab
BR112013029778A2 (pt) composição farmacêutica que compreende fexofenadina
IT1403105B1 (it) Struttura di orologio da polso.
CL2015001502A1 (es) Composición farmacéutica que comprende desloratadina y prendnisolona y uso de la misma.